73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
AI predicts cancer patients' symptoms

AI predicts cancer patients' symptoms

by University of SurreyCredit: CC0 Public DomainDoctors could get a head start treating cancer thanks to new AI developed at the University of Surrey that is able to predict symptoms and their se

AI predicts cancer patients' symptoms

by University of SurreyCredit: CC0 Public DomainDoctors could get a head start treating cancer thanks to new AI developed at the University of Surrey that is able to predict symptoms and their se
No substantial benefit from transplantation reported for a high-risk leukemia subtype

No substantial benefit from transplantation reported for a high-risk leukemia subtype

by St. Jude Children's Research HospitalA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC BY-SA

No substantial benefit from transplantation reported for a high-risk leukemia subtype

by St. Jude Children's Research HospitalA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC BY-SA
Assay to ID anticancer reagents targeting fructose-1,6-bisphosphate aldolase

Assay to ID anticancer reagents targeting fructose-1,6-bisphosphate aldolase

by SLAS (Society for Laboratory Automation and Screening)ALDOA catalyzes the reversible aldol cleavage of fructose-1,6-bisphosphate (F-1,6-BP) into D-Glyceraldehyde-3-phosphate (GAP) and dihydroxyacet

Assay to ID anticancer reagents targeting fructose-1,6-bisphosphate aldolase

by SLAS (Society for Laboratory Automation and Screening)ALDOA catalyzes the reversible aldol cleavage of fructose-1,6-bisphosphate (F-1,6-BP) into D-Glyceraldehyde-3-phosphate (GAP) and dihydroxyacet
Study: Anti-PD-L1 antibody enhances curative effect of cryoablation

Study: Anti-PD-L1 antibody enhances curative effect of cryoablation

by Compuscript LtdGraphical abstract. Credit:Acta Pharmaceutica Sinica B(2022). DOI: 10.1016/j.apsb.2022.08.006A new article published inActa Pharmaceutica Sinica Bdiscusses ho

Study: Anti-PD-L1 antibody enhances curative effect of cryoablation

by Compuscript LtdGraphical abstract. Credit:Acta Pharmaceutica Sinica B(2022). DOI: 10.1016/j.apsb.2022.08.006A new article published inActa Pharmaceutica Sinica Bdiscusses ho
Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an accepta

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an accepta
Researchers share insights on the evolution of proton radiotherapy

Researchers share insights on the evolution of proton radiotherapy

by Mass General BrighamCredit: Unsplash/CC0 Public DomainIn a review article published inThe Lancet Oncology, Susu Yan, Ph.D., and Thomas Bortfeld, Ph.D., from the Biophysics Division of MG

Researchers share insights on the evolution of proton radiotherapy

by Mass General BrighamCredit: Unsplash/CC0 Public DomainIn a review article published inThe Lancet Oncology, Susu Yan, Ph.D., and Thomas Bortfeld, Ph.D., from the Biophysics Division of MG
Lost metabolic fitness of CAR NK cells is key mechanism of tumor resistance, study discovers

Lost metabolic fitness of CAR NK cells is key mechanism of tumor resistance, study discovers

byUniversity of Texas M. D. Anderson Cancer CenterCAR-NK cells have a distinct single-cell transcriptome and metabolic profile. Credit:Science Advances(2023). DOI: 10.1126/sciadv.add

Lost metabolic fitness of CAR NK cells is key mechanism of tumor resistance, study discovers

byUniversity of Texas M. D. Anderson Cancer CenterCAR-NK cells have a distinct single-cell transcriptome and metabolic profile. Credit:Science Advances(2023). DOI: 10.1126/sciadv.add
Tumor-specific therapy targets ovarian cancer

Tumor-specific therapy targets ovarian cancer

by Anna Zarra Aldrich,University of ConnecticutUConn professor Xiuling Lu with members of her lab team at the School of Pharmacy on Nov. 8, 2018. Credit: (Sean Flynn/UConn Photo)Nami Therapeutic

Tumor-specific therapy targets ovarian cancer

by Anna Zarra Aldrich,University of ConnecticutUConn professor Xiuling Lu with members of her lab team at the School of Pharmacy on Nov. 8, 2018. Credit: (Sean Flynn/UConn Photo)Nami Therapeutic
Researchers uncover new sarcoma gene

Researchers uncover new sarcoma gene

by Harry Perkins Institute of Medical ResearchCredit: CC0 Public DomainA team of WA researchers has uncovered new genes that could play an important role in the development of sarcoma, a group of

Researchers uncover new sarcoma gene

by Harry Perkins Institute of Medical ResearchCredit: CC0 Public DomainA team of WA researchers has uncovered new genes that could play an important role in the development of sarcoma, a group of
Specific components of the tumor immune microenvironment may affect responses to BCMA CAR T-cell therapy

Specific components of the tumor immune microenvironment may affect responses to BCMA CAR T-cell therapy

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with myeloma whose tumor immune microenvironments had a more diverse baseline T-cell repertoire, fewer marker

Specific components of the tumor immune microenvironment may affect responses to BCMA CAR T-cell therapy

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with myeloma whose tumor immune microenvironments had a more diverse baseline T-cell repertoire, fewer marker
Oncology trial shows positive results for patients with muscle-invasive urothelial carcinoma

Oncology trial shows positive results for patients with muscle-invasive urothelial carcinoma

JANUARY 26, 2024by Alliance for Clinical Trials in OncologyCredit: Pixabay/CC0 Public DomainPatients with muscle-invasive urothelial cancer and a high risk of recurrence after surgery may have a new t

Oncology trial shows positive results for patients with muscle-invasive urothelial carcinoma

JANUARY 26, 2024by Alliance for Clinical Trials in OncologyCredit: Pixabay/CC0 Public DomainPatients with muscle-invasive urothelial cancer and a high risk of recurrence after surgery may have a new t
Erectile dysfunction drugs and flu vaccine may work together to help immune system fight cancer after surgery

Erectile dysfunction drugs and flu vaccine may work together to help immune system fight cancer after surgery

by The Ottawa HospitalNew research shows that erectile dysfunction drugs and flu vaccine may work together to help the immune system fight cancer after surgery. Credit: The Ottawa HospitalA new study

Erectile dysfunction drugs and flu vaccine may work together to help immune system fight cancer after surgery

by The Ottawa HospitalNew research shows that erectile dysfunction drugs and flu vaccine may work together to help the immune system fight cancer after surgery. Credit: The Ottawa HospitalA new study